Literature DB >> 14740344

[Insulin resistance in polycystic ovary syndrome].

Annika K Schröder1, Sascha Tauchert, Olaf Ortmann, Klaus Diedrich, Jürgen M Weiss.   

Abstract

With a prevalence of 5-10% the polycystic ovary syndrome (PCOS) is a common disorder of premenopausal women. According to prospective studies abnormal glucose tolerance and diabetes mellitus present in about 10.0% and 35.0% of adult women with PCOS, respectively. PCOS patients have a higher prevalence of cardiovascular risk factors such as hypertension and dyslipidaemia. The rate of spontaneous abortions as well as the risk of developing gestational diabetes is increased in PCOS. Therefore, PCOS is not only a reproductive problem, but a complex endocrine disease with important health implications. The role of glucose metabolism in PCOS, the health consequences and possible interventions are reviewed in this article.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14740344     DOI: 10.1007/bf03041041

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  83 in total

Review 1.  Candidate genes in polycystic ovary syndrome.

Authors:  S Franks; N Gharani; M McCarthy
Journal:  Hum Reprod Update       Date:  2001 Jul-Aug       Impact factor: 15.610

2.  The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.

Authors:  J J Conn; H S Jacobs; G S Conway
Journal:  Clin Endocrinol (Oxf)       Date:  2000-01       Impact factor: 3.478

3.  Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.

Authors:  Mark R Palmert; Catherine M Gordon; Alex I Kartashov; Richard S Legro; S Jean Emans; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

4.  Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome.

Authors:  Ghina Ghazeeri; William H Kutteh; Michael Bryer-Ash; Derek Haas; Raymond W Ke
Journal:  Fertil Steril       Date:  2003-03       Impact factor: 7.329

5.  Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

Authors:  R J Norman; L Masters; C R Milner; J X Wang; M J Davies
Journal:  Hum Reprod       Date:  2001-09       Impact factor: 6.918

Review 6.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

7.  Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.

Authors:  Jeffrey A Johnson; Sumit R Majumdar; Scot H Simpson; Ellen L Toth
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

Review 8.  Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women.

Authors:  E Carmina; R A Lobo
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

9.  Defects in beta-cell function in functional ovarian hyperandrogenism.

Authors:  N M O'Meara; J D Blackman; D A Ehrmann; R B Barnes; J B Jaspan; R L Rosenfield; K S Polonsky
Journal:  J Clin Endocrinol Metab       Date:  1993-05       Impact factor: 5.958

10.  Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome.

Authors:  L J Moran; M Noakes; P M Clifton; L Tomlinson; C Galletly; R J Norman
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

View more
  2 in total

1.  Lack of association between interleukin-1a gene (IL-1a) C (-889) T variant and polycystic ovary syndrome in Chinese women.

Authors:  Binbin Wang; Sirui Zhou; Jing Wang; Jingjing Liu; Feng Ni; Chunmei Liu; Jinting Yan; Yuan Mu; Yunxia Cao; Xu Ma
Journal:  Endocrine       Date:  2009-02-04       Impact factor: 3.633

2.  Anti-mullerian hormone levels before and after ovarian drilling in polycystic ovary syndrome: has this an effect on fertility?

Authors:  Mojgan Javedani Masroor; Hossein Sheybani; Shiva Sheybani; Nastaran Abolghasem
Journal:  Reprod Biol Endocrinol       Date:  2022-08-30       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.